ArticleThe Journal of thoracic and cardiovascular surgery2026
Severity and timing of elevated lactate correlates with mortality after cardiac surgery.
Article in The Journal of thoracic and cardiovascular surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveExtreme serum hyperlactatemia is common after cardiac surgery but can portend organ ischemia and mortality. Thus, we sought to determine which lactate thresholds warrant concern at various time points after cardiac surgery. We hypothesized that post-cardiac surgery lactate correlates with operative mortality and is most strongly associated with risk outside of the immediate post-bypass period.
methodsAll adult patients at a quaternary institution undergoing coronary artery bypass graft and/or valve procedures with recorded Society of Thoracic Surgeons Predicted Risk of Mortality (PROM) scores, peak postoperative lactate, and time to postoperative peak lactate from 2012 to 2024 were included for analysis. The correlation between lactate and operative mortality was modeled using logit-transformed PROM (log-PROM)-adjusted logistic regression.
resultsIn total, 7292 patients (PROM score, 2.4%) met inclusion criteria (median lactate, 2.3 mmol/L). The operative mortality rate was 1.4% (n = 103). On log-PROM-adjusted analysis, a postoperative peak lactate >5 mmol/L (P < .001) was associated with increased mortality risk (mortality rate, 9.8% [66/672]). Moreover, mortality risk dramatically increased with a postoperative peak lactate ≥7 mmol/L (mortality rate, 17.5% [52/297]). Only 6% (n = 444) of patients experienced peak hyperlactatemia >24 hours postoperatively. On adjusted analysis, later lactate peaks demonstrated greater model discrimination than peak lactates collected in the first postoperative 24 hours (>24-hour area under curve [AUC], 0.94; ≤24-hour AUC, 0.79).
conclusionsPeak lactate values >5 mmol/L correlate with increased mortality risk. Mortality risk increases drastically at lactates above 7 mmol/L. Early hyperlactatemia is less concerning, while after the first 24 hours postoperatively, there is a strong correlation between peak lactate and mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.